| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |